Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Binary Fission01:26

Binary Fission

2.5K
Binary fission is the primary mode of asexual reproduction in prokaryotes, such as bacteria. It results in the production of two genetically identical daughter cells. This highly efficient process ensures the rapid propagation of bacterial populations under favorable conditions and involves coordinated cellular and molecular events.DNA Replication and SeparationThe process begins with the replication of the bacterial chromosome. The circular DNA molecule unwinds at a specific origin of...
2.5K
Binary Fission01:20

Binary Fission

63.0K
Fission is the division of a single entity into two or more parts, which regenerate into separate entities that resemble the original. Organisms in the Archaea and Bacteria domains reproduce using binary fission, in which a parent cell splits into two parts that can each grow to the size of the original parent cell. This asexual method of reproduction produces cells that are all genetically identical.
63.0K
Protein Networks02:26

Protein Networks

4.5K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.5K
Network Covalent Solids02:18

Network Covalent Solids

16.1K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.1K
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

250
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
250
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

536
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
536

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incorporating Auxiliary Information into Assessment of Accuracy and Discrimination of Risk Models When Some Predictors are Missing.

Statistics in medicine·2026
Same author

A Surrogate-Calibrated Updating Method for Logistic Regression With Missing Covariates.

Statistics in medicine·2026
Same author

SUPERVISED LEARNING OF OUTCOME-RELEVANT ITEMS FROM A QUESTIONNAIRE VIA MIXED INTEGER OPTIMIZATION.

The annals of applied statistics·2026
Same author

Community-level wastewater surveillance with machine learning methods to assess underreporting of COVID-19 case counts.

mLife·2026
Same author

Prediction of transition probabilities in multi-state models with nested case-control data.

Biometrics·2025
Same author

Dynamic prediction by landmarking with data from cohort subsampling designs.

Statistical methods in medical research·2025
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
Same journal

Finite mixtures of linear quantile regressions with concomitant variables: a solution to endogeneity in longitudinal data modeling.

Biometrics·2026
Same journal

Discussion on "INTACT: a method for integration of longitudinal physical activity data from multiple sources" by Jingru Zhang, Erjia Cui, Hongzhe Li, and Haochang Shou.

Biometrics·2026
See all related articles

Related Experiment Video

Updated: Jan 22, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.2K

Autologistic network model on binary data for disease progression study.

Yei Eun Shin1, Huiyan Sang2, Dawei Liu3

  • 1Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.

Biometrics
|June 30, 2019
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical model for analyzing spatiotemporal data, particularly useful for understanding diseases like amyotrophic lateral sclerosis (ALS) and predicting disease progression.

Keywords:
absorbing statesamyotrophic lateral sclerosis diseasebias-corrected LASSOnetworkpenalized peudolikelihood estimationspatiotemporal dependence

More Related Videos

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

20.9K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.7K

Related Experiment Videos

Last Updated: Jan 22, 2026

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
14:27

Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data

Published on: June 26, 2013

16.2K
A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS
06:49

A Quick Phenotypic Neurological Scoring System for Evaluating Disease Progression in the SOD1-G93A Mouse Model of ALS

Published on: October 6, 2015

20.9K
Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
08:41

Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease

Published on: March 24, 2023

1.7K

Area of Science:

  • Biostatistics
  • Statistical modeling
  • Network analysis

Background:

  • Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease affecting muscle strength across multiple body regions.
  • Analyzing the spatiotemporal spread of ALS requires models that capture complex dependencies between affected areas.
  • Existing models often rely on predefined spatial neighborhoods, which may not accurately reflect disease progression patterns.

Purpose of the Study:

  • To develop a novel autologistic regression model for analyzing spatiotemporal binary data with absorbing states.
  • To empirically identify underlying network structures representing disease spread, rather than relying on predefined spatial proximity.
  • To predict disease status in future time intervals based on observed patterns.

Main Methods:

  • Proposed an autologistic regression model to account for spatial and temporal dependencies in muscle strength.
  • Developed a method to empirically identify network structures, allowing for flexible disease spread patterns.
  • Utilized penalized pseudo-likelihood maximization for parameter estimation and bias-correction for inference.
  • Derived asymptotic distributions for post-model selection inference.

Main Results:

  • The proposed model effectively captures complex spatiotemporal dependencies in binary data.
  • Empirical network identification allows for a more realistic representation of disease spread.
  • The model enables accurate prediction of disease status in subsequent time intervals.
  • Simulation studies validated the performance and robustness of the proposed method.

Conclusions:

  • The developed autologistic regression model offers a flexible and powerful approach for analyzing spatiotemporal binary data, particularly in clinical settings like ALS research.
  • The empirical network identification addresses limitations of predefined neighborhood structures, providing deeper insights into disease progression.
  • This methodology facilitates improved prediction of disease status, aiding in clinical management and therapeutic strategy development.